Solid Tumors (Phase 1)
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AN
Trial Timeline
Clinical trial activity over time
2026
2027
2028
2029
AdcendoADCE-B05
Adlai NortyeAN9025 oral capsule
Clinical Trials (2)
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
Start: Mar 2026Est. completion: Mar 2029
Phase 1Not Yet Recruiting
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Start: Jan 2026Est. completion: Jun 2028
Phase 1Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
Just now
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
Just now
Office Administrator
SystImmune
Just now
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
11m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
14m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
14m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
2 companies competing in this space